HOWARD UNIVERSITY HOSPITAL
1. Target Overview & Investment Thesis
HOWARD UNIVERSITY HOSPITAL is a 215-bed suburban community hospital in DC, DC with $294.6M in net patient revenue and a -8.4% operating margin. The hospital serves a payer mix of 22.7% Medicare, 12.3% Medicaid, and 65.0% commercial.
Thesis: Undervalued. Our ML models identify $21.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -8.4% to -1.1% (+736bps).
| Net Revenue HCRIS | $294.6M |
| Current EBITDA COMPUTED | $-24.9M |
| Operating Margin COMPUTED | -8.4% |
| Occupancy HCRIS | 60.6% |
| Revenue / Bed COMPUTED | $1.4M |
| Net-to-Gross HCRIS | 36.4% |
| Distress Probability ML | 48.3% |
2. Market Context & Competitive Position
DC has 12 Medicare-certified hospitals with a median operating margin of -2.9%. The target's margin of -8.4% places it below the state median. Among 8 size-comparable peers (108-430 beds), the median margin is -3.6%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (108-430), prioritizing same-state peers. 8 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| HOWARD UNIVERSITY HOSPITAL (Target) | DC | 215 | $294.6M | -8.4% |
| CHILDRENS HOSPITAL | DC | 323 | $1.36B | -8.2% |
| GEORGETOWN UNIVERSITY HOSPITAL | DC | 402 | $1.11B | 6.3% |
| GEORGE WASHINGTON UNIV HOSPITA | DC | 339 | $612.1M | -2.9% |
| SIBLEY MEMORIAL HOSPITAL | DC | 229 | $498.2M | -3.6% |
| NATIONAL REHABILITATION HOSPIT | DC | 137 | $164.0M | -7.2% |
| NOT-FOR-PROFIT HOSPITAL CORPOR | DC | 123 | $99.7M | -43.5% |
| PSYCH INSTITUE OF WASHINGTON | DC | 130 | $37.7M | 15.5% |
| ST. ELIZABETHS HOSPITAL | DC | 292 | $nan | nan% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $6.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $5.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $5.8M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $3.6M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $189K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-24.9M |
| + RCM Uplift | +$21.7M |
| Pro Forma EBITDA | $-3.2M |
| Current Margin | -8.4% |
| Pro Forma Margin | -1.1% |
| WC Released (1x) | $11.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-38.3M | $52.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-38.3M | $45.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-34.4M | $104.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-34.4M | $104.2M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-42.1M | $-43.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-42.1M | $-61.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 8 hospitals with 108-430 beds
- Same-state prioritization (n=9)
- Comp margins: P25=-7.7% / P50=-3.6% / P75=1.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.